Call for Abstract
11th International Conference on Vascular Dementia, will be organized around the theme “Decoding Dementia ”
Vascular Dementia 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Vascular Dementia 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, such as Alzheimer's disease, is usually progressive and can eventually be fatal. Dementia can be grouped based on the part of brain being affected. it is roughly true that the earliest symptoms in "cortical" dementia include difficulty with high-level behaviors such as memory, language, problem-solving and reasoning; these functions tend to be less impaired in "subcortical" dementia. Cortical dementia occurs because of damage in the cerebral cortex, the outer layer of the brain. They play a critical role in memory and language. The symptoms usually include severe memory loss. Alzheimer's and Creutzfeldt-Jakob disease are two forms of cortical dementia. Subcortical dementia occurs due to the damage to the part of the brain beneath the cortex. The person suffering from it can show changes in their speed of thinking. Usually, people with subcortical dementia don't have forgetfulness and language problems. Parkinson's disease, Huntington's disease, and HIV are two forms subcortical dementia.
- Track 1-1Mixed dementia
- Track 1-2Frontotemporal dementia
- Track 1-3Neurogenesis in dementia
- Track 1-4Global prevalence of dementia
- Track 1-5Signs and symptoms of dementia
- Track 1-6Primary mental health care and nursing
- Track 1-7Novel therapeutics technology
- Track 1-8Novel therapeutics strategies for Dementia
Vascular dementia is the broad term for dementia associated with problems of circulation of blood to the brain. There are a number of different types of Vascular dementia. Two of the most common are Multi-infarct dementia and Binswanger's disease. The multi-infarct dementia (MID) and vascular intellectual impedance is dementia caused by issues in the supply of blood to the mind, normally a progression of minor strokes. People with vascular dementia give dynamic subjective hindrance, intensely or sub acutely as in mellow psychological debilitation, every now and again step-wise, after various cerebrovascular occasions (strokes). A few people may seem to enhance amongst occasions and decrease after more noiseless strokes. A quickly decaying condition may prompt demise from a stroke, coronary illness, or infection. Vascular dementia can be caused by ischemic or hemorrhagic infarcts influencing numerous mind regions, including the foremost cerebral supply route domain, the parietal projections, or the cingulate gurus.
- Track 2-1Vascular dementia prognosis
- Track 2-2Young onset dementia
- Track 2-3Multi-infarct dementia
- Track 2-4Parkinson dementia
- Track 2-5Advences in vascular dementia therapy
Lewy body is also known as dementia with Lewy bodies, with Lewy body dementia is the second most common type of progressive dementia after Alzheimer's disease dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).
Lewy body dementia is also causes a progressive decline in mental abilities. The people with Lewy body dementia may experience visual hallucinations and changes in the alertness and attention and other effects include Parkinson's disease-like symptoms such as rigid muscles, slow movement and tremors.
- Track 3-1Risk factor of vascular dementia
- Track 3-2Antipsychotic medications
- Track 3-3Antipsychotic medications
- Track 3-4Palliative care in vascular dementia
- Track 3-5Autophagy
- Track 3-6Synucleinopathies
- Track 4-1Cerebral amyloid angiopathy
- Track 4-2Normal pressure hydrocephalus
- Track 4-3FDG-PET
- Track 4-4Amyloid Immunotherapy
- Track 4-5Beta amyloid protein
Alzheimer's disease (AD) is the most common form of dementia among older people. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. AD begins slowly. It first involves the parts of the brain that control thought, memory and language. People with AD may have trouble remembering things that happened recently or names of people they know. A related problem, mild cognitive impairment (MCI), causes more memory problems than normal for people of the same age. Many, but not all, people with MCI will develop AD.
- Track 5-1Stages of alzheimers
- Track 5-2Diagnosis of alzheimers
- Track 5-3Risk factors of alzheimers
- Track 5-4Clinical studies of alzheimers
- Track 5-5Treatments of alzheimers
Degenerative nerve diseases affect many of your body's activities, such as balance, movement, talking, breathing, and heart function. Many of these diseases are genetic. Sometimes the cause is a medical condition such as alcoholism, a tumor, or a stroke. Other causes may include toxins, chemicals, and viruses. Sometimes the cause is not known.
- Track 6-1Stroke
- Track 6-2Spinal muscular atrophy (SMA)
- Track 6-3Spinocerebellar ataxia (SCA)
- Track 6-4Huntington’s disease (HD)
- Track 6-5Motor neurone diseases (MND)
- Track 6-6Prion disease
- Track 6-7Parkinson’s disease (PD) and PD-related disorders
- Track 6-8Traumatic brain injury: TBI
- Track 6-9Brain Injury
- Track 6-10Epilepsy
- Track 7-1Migraine
- Track 7-2Trauma
- Track 7-3Trauma
- Track 7-4Seizures
- Track 7-5Encephalitis
- Track 7-6Arteriovenous malformation.
- Track 7-7Bipolar disorder
- Track 7-8Motor neuron disease
- Track 7-9Attention deficit hyperactivity disorder
- Track 7-10Brain abscess
Almost 42% of people over the age of 64 experience some form of memory loss. When there is no underlying medical condition causing this memory loss, it is known as "age-associated memory impairment," which is considered a part of the normal aging process.
- Track 8-1Neuro-anatomical changes in ageing
- Track 8-2Risk factors of cognitive decline
- Track 8-3Granulovacuolar degeneration
- Track 8-4Changes in cerebral cortical microvasculature
- Track 8-5Advances of research in ageing and dementia
The developing number of Dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance Alzheimer's patients and guardians care and administrations conveyance. Treatment of dementia relies on upon its cause. On account of most dynamic dementia, including Alzheimer's disease there is no cure and no treatment that moderates or stops its movement. In any case, there are medicating medicines that may briefly enhance side effects. Similar pharmaceuticals used to treat Alzheimer's are among the medications once in a while endorsed to help with side effects of different sorts of dementia. Non-sedate treatments can likewise reduce a few manifestations of Dementia. The increasing number of cognitively impaired older adults who exhibit wandering tendencies raises safety concerns. The purpose of the current study in neurology was to research the State-of the-Art in wearable technologies for persons with Alzheimer's disease and identify challenges unique to this population and lessons learned. Inclusion criteria specified systems that completed laboratory testing and were commercially available for usage by community-based Alzheimer's family caregivers.
- Track 9-1Advances in dementia care management
- Track 9-2Dementia care management program
- Track 9-3Undernutrition and obesity in dementia
- Track 9-4Advance care planning
People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects aphasia, apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities. Furthermore, people with dementia commonly experience the ill effects of comorbid conditions that extra confuse mind and block best results. Along these lines, creating caregiving techniques individuals with vascular dementia is pressing, given this expanding commonness and consequently the related weight that dementia places not just on the people, however on the parental figures, relations, and thusly the assets of the human services framework. Traditional perspectives bearing on geriatric nursing ordinarily paint a picture of the care as being moderate paced certain and less requesting than intense care. Be that as it may, care of the matured, and especially those with vascular dementia, is normally confounded, unusual, and flimsy.
- Track 10-1Dementia nursing care plan
- Track 10-2Music therapy in dementia
- Track 10-3Physiotherapy for dementia
- Track 10-4Clinical features of dementia
- Track 10-5Therapeutic interventions in dementia
Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable .Ischemic changes in the cerebrum are irreversible, however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus. Meta-examinations have discovered that meds for hypertension are viable at counteractive action of pre-stroke dementia, which implies that hypertension treatment ought to be begun early .These drugs incorporate angiotensin changing over protein inhibitors, diuretics, calcium channel blockers, thoughtful nerve inhibitors, angiotensin II receptor opponents or adrenergic foes. Raised lipid levels, including HDL, were found to expand danger of vascular dementia. Ibuprofen is a medicine that is ordinarily recommended for counteractive action of strokes and heart assaults; it is likewise every now and again given to patients with dementia.
- Track 11-1Psychopharmacological treatment
- Track 11-2Psychopharmacological treatment
- Track 11-3Advanced drugs for dementia
- Track 11-4Cognitive behavioral therapy
- Track 11-5Family therapy in nursing
Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other. This article will concentrate on both behavioral and atomic neuropharmacology; the real receptors, particle channels, and neurotransmitters controlled through medication activity and how individuals with a neurological issue advantage from this medication activity.
- Track 12-1Neuroscience and neuropharmacology
- Track 12-2Neurochemical interaction
- Track 12-3Molecular neuropharmacology
- Track 12-4Behavioral neuropharmacology
- Track 12-5Advance research in neuropharmacology
Novel therapeutics is a standout amongst the most energizing uses of data preparing frameworks is in diagnostics and treatment. This is not astonishing, given that illness analysis is in its center a data handling undertaking that finishes with a choice. In numerous infections, the conclusion can be performed in singular cells.
- Track 13-1Novel therapeutics strategies for Dementia
- Track 13-2Novel therapeutics technology
- Track 13-3Novel therapeutics molecule
- Track 13-4Anti-dementia drugs
- Track 13-5Novel drug target for the treatment of dementia
The animal models of Dementia and Alzheimer's diseasefor pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.
- Track 14-1Animal models of human cognitive aging
- Track 14-2Genetics of translational models
- Track 14-3Protein-protein interactions
- Track 14-4Pre-clinical testing and clinical translation
- Track 14-5Neurobehavioral Toxicology Testing
It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro-oncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects.
- Spine Cancer and Spine Cancer Treatment
- Brain Stem Tumors
- Malignant Brain Cancers and Brain Metastasis
- Pediatric Neuro Oncology
- Risk Factors
- Radiation Therapy And Chemotherapy